Evidence map›Paper›PMID 34920757›Full record

ArticleEuropean journal of medical research2021

Establishment of a quantitative RT-PCR detection of SARS-CoV-2 virus.

Yushen Jiang, Shanming Zhang, Hong Qin, Shuai Meng, Xuyi Deng, He Lin, Xiaoliang Xin, Yuxin Liang, Bowen Chen, Yan Cui and 4 more

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yushen JiangRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China. jiang_yushen@163.com.
Shanming ZhangTeddy Clinical Research Laboratory (Shanghai) Limited, Shanghai, 200433, China.
Hong QinTeddy Clinical Research Laboratory (Shanghai) Limited, Shanghai, 200433, China.
Shuai MengRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
Xuyi DengJiangxi DIAN-HUAXING Medical Laboratories, NanChang, 330029, China.
He LinTianjin DIAN Medical Laboratories, Tianjin, 300300, China.
Xiaoliang XinRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
Yuxin LiangRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
Bowen ChenRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
Yan CuiRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
YiHeng SuRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
Pei LiangRapid Diagnostics Laboratory, Hangzhou DIAN Medical Laboratories, No. 329 of Jinpeng Street, Xihu District, Hangzhou, 310030, China.
GuangZhi ZhouWuHan DIAN Medical Laboratories, Wuhan, 430034, China.
Hongbo HuWuHan DIAN Medical Laboratories, Wuhan, 430034, China.
Dian Diagnostics (China) · CNShanghai Clinical Research Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe outbreak of novel coronavirus disease 2019 (COVID-19) has become a public health emergency of international concern. Quantitative testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus is demanded in evaluating the efficacy of antiviral drugs and vaccines and RT-PCR can be widely deployed in the clinical assay of viral loads. Here, we developed a quantitative RT-PCR method for SARS-CoV-2 virus detection in this study.

methodsRT-PCR kits targeting E (envelope) gene, N (nucleocapsid) gene and RdRP (RNA-dependent RNA polymerase) gene of SARS-CoV-2 from Roche Diagnostics were evaluated and E gene kit was employed for quantitative detection of COVID-19 virus using Cobas Z480. Viral load was calculated according to the standard curve established by series dilution of an E-gene RNA standard provided by Tib-Molbiol (a division of Roche Diagnostics). Assay performance was evaluated.

resultsThe performance of the assay is acceptable with limit of detection (LOD) below 10E1 copies/μL and lower limit of quantification (LLOQ) as 10E2 copies/μL.

conclusionA quantitative detection of the COVID-19 virus based on RT-PCR was established.

Indexed as

Coronavirus Envelope ProteinsCoronavirus Nucleocapsid ProteinsCoronavirus RNA-Dependent RNA PolymeraseCOVID-19HumansLimit of DetectionPhosphoproteinsReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Viral LoadCoronavirus Envelope ProteinsCoronavirus Nucleocapsid ProteinsCoronavirus RNA-Dependent RNA Polymeraseenvelope protein, SARS-CoV-2NSP12 protein, SARS-CoV-2nucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsCOVID-19QuantitativeRNART-PCRSARS-CoV-2 virus

Identifiers

PMID34920757
PMCPMC8677905
OpenAlexW4200454490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.